Have a feature idea you'd love to see implemented?
Let us know!
MDWD MediWound Ltd
Price (delayed)
$16.76
Market cap
$154.76M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.16
Enterprise value
$157.33M
mediwound is a fully-integrated biopharmaceutical company focused on developing, manufacturing and commercializing novel therapeutics based on its patented proteolytic enzyme technology to address unmet needs in the fields of severe
Highlights
The EPS has dropped by 57% since the previous quarter but it has increased by 10% year-on-year
MDWD's gross profit has dropped by 79% year-on-year and by 21% since the previous quarter
The company's gross margin has shrunk by 72% YoY and by 21% QoQ
Key stats
What are the main financial stats of MDWD
Market
Valuations
Earnings
Shares outstanding
9.23M
Market cap
$154.76M
Enterprise value
$157.33M
Price to earnings (P/E)
N/A
Price to book (P/B)
8.66
Price to sales (P/S)
7.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.81
Revenue
$20.14M
EBIT
-$3.9M
EBITDA
-$2.49M
Free cash flow
-$22.27M
Per share
Balance sheet
Liquidity
EPS
-$2.16
Free cash flow per share
-$2.4
Book value per share
$1.94
Revenue per share
$2.17
TBVPS
$6.16
Total assets
$57.3M
Total liabilities
$39.43M
Debt
$6.36M
Equity
$17.87M
Working capital
$14.7M
Debt to equity
0.36
Current ratio
1.65
Quick ratio
1.52
Net debt/EBITDA
-1.03
Margins
Efficiency
Dividend
EBITDA margin
-12.4%
Gross margin
13.3%
Net margin
-99.2%
Operating margin
-76.2%
Return on assets
-31.6%
Return on equity
-75.6%
Return on invested capital
-10.6%
Return on capital employed
-11.3%
Return on sales
-19.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MDWD stock price
How has the MediWound stock price performed over time
Intraday
-0.12%
1 week
2.38%
1 month
-2.05%
1 year
99.52%
YTD
64.8%
QTD
-7.2%
Financial performance
How have MediWound's revenue and profit performed over time
Revenue
$20.14M
Gross profit
$2.67M
Operating income
-$15.35M
Net income
-$19.97M
Gross margin
13.3%
Net margin
-99.2%
The company's operating margin has shrunk by 111% YoY
MediWound's net margin has shrunk by 79% YoY and by 55% QoQ
MDWD's gross profit has dropped by 79% year-on-year and by 21% since the previous quarter
The company's gross margin has shrunk by 72% YoY and by 21% QoQ
Growth
What is MediWound's growth rate over time
Valuation
What is MediWound stock price valuation
P/E
N/A
P/B
8.66
P/S
7.72
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
7.81
The EPS has dropped by 57% since the previous quarter but it has increased by 10% year-on-year
MDWD's P/B is 77% above its last 4 quarters average of 4.9 but 34% below its 5-year quarterly average of 13.1
The equity has declined by 49% year-on-year and by 23% since the previous quarter
The P/S is 93% higher than the 5-year quarterly average of 4.0 and 35% higher than the last 4 quarters average of 5.7
MediWound's revenue has decreased by 23% YoY
Efficiency
How efficient is MediWound business performance
MDWD's ROE has shrunk by 82% QoQ and by 6% YoY
MDWD's ROIC has soared by 79% year-on-year
The ROA has plunged by 61% from the previous quarter and by 16% YoY
The return on sales has declined by 28% year-on-year
Dividends
What is MDWD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MDWD.
Financial health
How did MediWound financials performed over time
The company's total assets is 45% higher than its total liabilities
The company's quick ratio has shrunk by 50% YoY and by 17% QoQ
MDWD's current ratio is down by 49% year-on-year and by 17% since the previous quarter
MediWound's debt is 64% lower than its equity
The equity has declined by 49% year-on-year and by 23% since the previous quarter
MediWound's debt to equity has increased by 29% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.